Zentalis Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 36 U.S.-traded ETFs. ZNTL has around 3.2M shares in the U.S. ETF market. The largest ETF holder of ZNTL is the SPDR S&P Biotech ETF (XBI), with approximately 1.04M shares. Investors may also find of interest that the ETF with the largest allocation to ZNTL stock is SPDR S&P Biotech ETF (XBI), with a portfolio weight of 0.87%. On average, U.S. ETFs allocate 0.14% of ZNTL to their portfolios.
Additionally, ZNTL is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ZNTL as a holding is the iShares Morningstar Small-Cap ETF (ISCB), with a return of 592.66%.